Affiliation:
1. Otolaryngology, Foltra Medical Center, Travesía Montouto 24, Teo 15886, Spain
2. Scientific Direction, Foltra Medical Center, Teo 15886, Spain
Abstract
The acute phase of vertigo involves multiple neurotransmitters, inflammatory mediators, and products of oxidative stress. The vestibular pathway has multiple melatonin receptors distributed along its path, both centrally and peripherally. In addition, melatonin has been shown to be a powerful antioxidant and anti-inflammatory agent against factors related to vertigo, such as Bax/caspases, interleukins, and chemokines. Likewise, it exerts central GABAergic, antidopaminergic, and anti-migraine functions and regulates sympathetic activity in a similar way to the drugs classically used in acute vestibular crisis. In this review, the role of melatonin as a potential treatment of the acute phase of vertigo is discussed.
Reference68 articles.
1. The inner ear and the neurologist
2. A review of common peripheral and central vestibular disorders;T. L. Thopson;Ochsner Journal,2009
3. Neuropharmacology of Vestibular System Disorders
4. Vestibular rehabilitation ameliorates chronic dizziness through the SIRT1 axis
5. Pharmacoepigenetics of vertigo and related vestibular syndromes;J. Guerra,2019
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献